Master Innovator
Vishnukant Bhutada’s big bet on oncology has catapulted Shilpa Medicare into the global generics space
Shilpa Elizabeth Abraham - June 09, 2017
Daljeet Singh Kohli
The time has come for Shilpa Medicare to reap the benefits of the hard work done by its management over the past few years
January 13, 2017
Paisa wise rupee foolish
Many stocks are trading at a low price but one should be wary of buying them
Jitendra Kumar Gupta - December 09, 2016
Daljeet Singh Kohli
Daljeet Singh Kohli of IndiaNivesh says Force Motors has more room to grow as luxury car demand takes off
Daljeet Singh Kohli - December 09, 2015
Time to sow Kaveri Seeds
Once an investor favourite, Kaveri Seeds has taken a beating due to aggressive accounting
Jash Kriplani - December 07, 2015
Why rate-sensitive stocks aren't attractive yet?
There is disagreement on whether RBI’s latest rate cut can revive demand
Jash Kriplani - October 01, 2015
Daljeet Singh Kohli
IndiaNivesh's head of research feels Lumax Auto will ride the recovery in the auto business
May 11, 2015